KBC Group NV Sells 10,347 Shares of Humana Inc. (NYSE:HUM)

KBC Group NV trimmed its position in Humana Inc. (NYSE:HUM) by 21.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,646 shares of the insurance provider’s stock after selling 10,347 shares during the period. KBC Group NV’s holdings in Humana were worth $12,241,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Pzena Investment Management LLC boosted its position in shares of Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955,375 shares in the last quarter. Marshall Wace LLP boosted its holdings in Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after acquiring an additional 774,085 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after acquiring an additional 738,701 shares during the last quarter. Steadfast Capital Management LP acquired a new position in shares of Humana during the first quarter valued at about $158,813,000. Finally, Baupost Group LLC MA purchased a new position in shares of Humana in the 2nd quarter valued at approximately $156,933,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on HUM shares. UBS Group dropped their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Royal Bank of Canada dropped their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. TD Cowen raised their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price target on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Finally, Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Stock Down 2.6 %

Humana stock opened at $275.67 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The stock has a market capitalization of $33.19 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The business has a 50 day simple moving average of $281.36 and a 200-day simple moving average of $331.61.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. On average, analysts anticipate that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.